Medivation, Inc. Announces Participation at Upcoming Investor Conference
Published: Mar 07, 2013
SAN FRANCISCO, CA--(Marketwire - March 06, 2013) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:
- Patrick Machado, chief business and financial officer, will present at the Barclays Global Healthcare Conference on March 12 at 1:30pm ET in Miami, FL.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.
Chief Business & Financial Officer
Sr. Director, Investor Relations